SE9500051D0 - Antioxidants, tissue- and/or neuroprotectants - Google Patents

Antioxidants, tissue- and/or neuroprotectants

Info

Publication number
SE9500051D0
SE9500051D0 SE9500051A SE9500051A SE9500051D0 SE 9500051 D0 SE9500051 D0 SE 9500051D0 SE 9500051 A SE9500051 A SE 9500051A SE 9500051 A SE9500051 A SE 9500051A SE 9500051 D0 SE9500051 D0 SE 9500051D0
Authority
SE
Sweden
Prior art keywords
tissue
formula
neuroprotectants
antioxidants
relates
Prior art date
Application number
SE9500051A
Other languages
English (en)
Inventor
Frode Rise
Lise-Lotte Grundersen
Sigurd Ugland
Haakan Wikstroem
Durk Dijkstra
Boer Peter De
Aalt Bast
Guido R M M Haenen
Original Assignee
Frode Rise
Haakan Wilhelm Wikstroem
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Frode Rise, Haakan Wilhelm Wikstroem filed Critical Frode Rise
Priority to SE9500051A priority Critical patent/SE9500051D0/sv
Publication of SE9500051D0 publication Critical patent/SE9500051D0/sv
Priority to AU44614/96A priority patent/AU4461496A/en
Priority to PCT/SE1996/000007 priority patent/WO1996021662A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic System
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE9500051A 1995-01-09 1995-01-09 Antioxidants, tissue- and/or neuroprotectants SE9500051D0 (sv)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE9500051A SE9500051D0 (sv) 1995-01-09 1995-01-09 Antioxidants, tissue- and/or neuroprotectants
AU44614/96A AU4461496A (en) 1995-01-09 1996-01-09 The use of heterocyclic compounds as antioxidants, radical scavengers, fe2+ complexing agents, tissue- and/or neuroprotectants
PCT/SE1996/000007 WO1996021662A1 (en) 1995-01-09 1996-01-09 THE USE OF HETEROCYCLIC COMPOUNDS AS ANTIOXIDANTS, RADICAL SCAVENGERS, Fe2+ COMPLEXING AGENTS, TISSUE- AND/OR NEUROPROTECTANTS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9500051A SE9500051D0 (sv) 1995-01-09 1995-01-09 Antioxidants, tissue- and/or neuroprotectants

Publications (1)

Publication Number Publication Date
SE9500051D0 true SE9500051D0 (sv) 1995-01-09

Family

ID=20396768

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9500051A SE9500051D0 (sv) 1995-01-09 1995-01-09 Antioxidants, tissue- and/or neuroprotectants

Country Status (3)

Country Link
AU (1) AU4461496A (sv)
SE (1) SE9500051D0 (sv)
WO (1) WO1996021662A1 (sv)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6525053B1 (en) 1997-08-22 2003-02-25 Abbott Laboratories Prostaglandin endoperoxide H synthase biosynthesis inhibitors
US6307047B1 (en) 1997-08-22 2001-10-23 Abbott Laboratories Prostaglandin endoperoxide H synthase biosynthesis inhibitors
US20070155738A1 (en) 2005-05-20 2007-07-05 Alantos Pharmaceuticals, Inc. Heterobicyclic metalloprotease inhibitors
KR20080104351A (ko) 2006-03-31 2008-12-02 노파르티스 아게 유기 화합물
WO2010071885A1 (en) 2008-12-19 2010-06-24 Cephalon, Inc. Pyrrolotriazines as alk and jak2 inhibitors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3333314A1 (de) * 1983-09-15 1985-03-28 Hoechst Ag, 6230 Frankfurt Substituierte pyrido(1,2-c)imidazo(1,2-a)benzimidazole, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen

Also Published As

Publication number Publication date
AU4461496A (en) 1996-07-31
WO1996021662A1 (en) 1996-07-18

Similar Documents

Publication Publication Date Title
ATE206123T1 (de) Phenylxanthin-derivate
BR9506828A (pt) Composição contendo nebivolol micronizado
BRPI9710372B8 (pt) composto, e, composição farmacêutica.
HUP0105437A2 (hu) Új malonsavszármazékok, előállításuk és alkalmazásuk, valamint e vegyületeket tartalmazó gyógyászati készítmények
ES2113127T3 (es) Derivado de androstenona.
IL92487A0 (en) Pharmaceutical and cosmetic compositions containing benzimidazoles and benzotriazoles,certain novel benzimidazoles and their preparation
ATE25977T1 (de) Furanonderivate, verfahren zu ihrer herstellung und ihre verwendung.
ES2036926A1 (es) "procedimiento para la obtencion de derivados de la (2-alquil-3-piridil)metilpiperazina".
CA2123232A1 (fr) Compositions pharmaceutiques a base d'ebastine ou de ses analogues
PT85502A (en) Process for the preparation of novel phenoxyacetic acid derivatives and of pharmaceutical compositions containing the same
NO912888D0 (no) Fremgangsmaate for fremstilling av nye peperidylethere og -thioethere.
SE9500051D0 (sv) Antioxidants, tissue- and/or neuroprotectants
CA2107485A1 (fr) Nouveaux derives d'ellipticine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
ATE13423T1 (de) Guanidinderivate und diese enthaltende pharmazeutische zusammensetzungen.
DE3750464D1 (de) Pharmazeutisches Präparat zur Behandlung des Katarakts.
GEP20032928B (en) Halo Derivatives of 9-Deoxo-9a-Aza-9a-Homerythromycin A, Method for its Production, Pharmaceutical Compositions Containing the Same and Their Use for Treatment or Prevention of Bacterial Infections
IL112630A (en) Derivatives of (2-(ar)alkyldithioindane-2-carboxamido) tricyclic-oxobenzazepine and similar compouds useful as inhibitors of enkephalinase, their preparation and pharmaceutical compositions containing them
NO166713C (no) Analogifremgangsmaate for fremstikling av terapeutisk aktive monobasiske diisobutamid derivater.
BG103395A (en) Derivatives of benzenesulphonamide and medicaments containing them
KR910002455A (ko) 아크릴산 유도체를 함유하는 제약 조성물 및 의약으로서 이들의 사용
DE69222143D1 (de) Indanderivate
KR890003734A (ko) 신규한 nf-1616-904의 피라진옥사이드 화합물 및 이를 함유하는 약학 조성물
DE3175674D1 (en) Novel dibenzoxepins, their preparation, compositions containing them and the use of dibenzoxepins in the treatment of allergic conditions
ZA944317B (en) New phosphonosuccinic acid derivatives processes for the preparation thereof and pharmaceutical compositions containing them
AU1041400A (en) Composition containing eugenol and polyphenols and use of such a composition forwound healing